Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Omar Serang and Jason Moore


DNANexus said this week that it has hired Omar Serang to be its chief cloud officer.

In his new role, Serang will work with DNANexus' product management and engineering teams to improve its cloud functionality and increase adoption of cloud-based service for analyzing and managing DNA data. He'll also be responsible for driving product development roadmaps and managing compliance and integration efforts as well as evaluating, designing, and implementing cloud security and governance features.

He joins the company from Amazon Web Services where he formed its Enterprise Cloud Transformation consulting practice and was responsible for designing and deploying cloud architectures as well as providing roadmap guidance to AWS service teams. Prior to that, he was an operations engineering manager at AWS and was responsible for its Elastic Compute Cloud service quality. Serang has also served in senior operations positions at Topsy Labs, Cloudmark and Critical Path.

He holds a BS degree from the University of California, Berkeley.

Jason Moore, a professor in Dartmouth College's Geisel School of Medicine has been named a Kavli Fellow of the National Academy of Sciences for 2013 for his work in translational bioinformatics and personalized medicine.

Moore is a professor of genetics and of community and family medicine at Geisel, director of Dartmouth's Institute for Quantitative Biomedical Sciences, and associate director for bioinformatics at Norris Cotton Cancer Center at Dartmouth.

He obtained his BS in biological sciences from Florida State University; and an MS in human genetics, an MA in applied statistics, and a PhD in human genetics all from the University of Michigan.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.